Bill

Bill > S1510


NJ S1510

Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.


summary

Introduced
02/13/2020
In Committee
02/13/2020
Crossed Over
Passed
Dead
01/11/2022

Introduced Session

2020-2021 Regular Session

Bill Summary

This bill prohibits the sale of certain items which use advertisements linked or alluding to controlled dangerous substances or analogs. The bill bans the sale of any food, beverage, or other product meant to be ingested or inhaled which uses the advertisement on its packaging or elsewhere. The bill further prohibits the sale of any product using the advertising, regardless of the product's intended use, to a person under 18 years of age. The bill specifies that the provisions do not apply to any prescription medication dispensed by a pharmacist pursuant to a valid prescription. A violation under the bill would be an unlawful practice under the consumer fraud act, which is punishable by a monetary penalty of not more than $10,000 for a first offense and not more than $20,000 for any subsequent offense. Additionally, a violation can result in a cease and desist order issued by the Attorney General, the assessment of punitive damages, and the awarding of treble damages and costs to the injured.

AI Summary

This bill prohibits the sale of certain products, such as food, beverages, or other ingestible or inhalable items, that use advertisements linked or alluding to controlled dangerous substances or analogs. The ban extends to the sale of any product, regardless of its intended use, to persons under 18 years of age. The bill does not apply to prescription medications dispensed by a pharmacist. Violations of the bill's provisions would be considered an unlawful practice under the consumer fraud act, resulting in monetary penalties, cease and desist orders, and the potential for treble damages and costs to be awarded to the injured party.

Committee Categories

Business and Industry

Sponsors (2)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/13/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...